COMMUNIQUÉS West-GlobeNewswire

Varian Launches HyperSight™ for TrueBeam in Asia Pacific: Boosting Accuracy and Efficiency in Radiotherapy Treatment

26/08/2024 - 04:04

Palo Alto, California, Aug. 26, 2024 (GLOBE NEWSWIRE) -- HyperSight extension to TrueBeam and Edge offers one of the most advanced in-room imaging systems in Asia Pacific region HyperSight improves adaptive planning [...]

Le KFSHRC établit de nouvelles normes mondiales en matière de formation aux soins de santé numériques

25/08/2024 - 14:54

RIYAD, Arabie saoudite, 25 août 2024 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital & Research Centre (KFSHRC) tire parti de technologies innovantes pour améliorer l’éducation et la formation médicales en [...]

Innovative Training and Simulation Propel KFSHRC to Global Leadership in Medical Education

25/08/2024 - 10:46

RIYADH, Saudi Arabia, Aug. 25, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) is revolutionizing clinical training through its iLearn Portal and comprehensive simulation-based [...]

KFSHRC Sets New Global Standards in Digital Healthcare Education

24/08/2024 - 12:21

RIYADH, Saudi Arabia, Aug. 24, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) is leveraging innovative technologies to enhance medical education and training, rolling out ground- [...]

Le KFSHRC propose des programmes de recherche innovants aux futurs leaders du secteur de la santé

24/08/2024 - 11:43

RIYAD, Arabie saoudite, 24 août 2024 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital & Research Centre (KFSHRC) renforce sa position de leader dans l’éducation et la recherche médicale grâce à son Département [...]

Capital and Business Alliance Formed Between MEDIROM MOTHER Labs and NFES Technologies

24/08/2024 - 03:12

NFES Group Selected as Lead Investor in Series A Round Valued at 9 Billion Yen TOKYO, Aug. 23, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Headquarters: Minato-ku, Tokyo; CEO: Koji Eguchi; listed on [...]

Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

24/08/2024 - 00:45

SAN DIEGO, Aug. 23, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for metabolic health, today announced [...]

IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q

23/08/2024 - 23:20

FRANKLIN, TN, Aug. 23, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (“IMAC” or the “Company”) (NASDAQ: BACK) today announced that it received an expected deficiency notification letter from the Listing Qualifications [...]

Entero Therapeutics, Inc. Receives Nasdaq Notification Regarding Delayed Form 10-Q

23/08/2024 - 23:00

BOCA RATON, Fla., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of [...]

Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing

23/08/2024 - 23:00

FLORHAM PARK, N.J., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (the “Company”), a regenerative and cellular medicine company developing placental-derived allogeneic cell therapies and advanced [...]

Cingulate Announces Adjournment of Special Meeting

23/08/2024 - 22:45

KANSAS CITY, Kan., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ:CING), (“Cingulate” or the “Company”), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery [...]

HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights - Correction

23/08/2024 - 22:30

This release has made a correction to a release issued under the same headline on August 14, 2024, by HCW Biologics, Inc. (NASDAQ: HCWB), to show the amount included in the condensed interim balance sheet for Cash and [...]

Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

23/08/2024 - 22:30

BRISBANE, Calif., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class 1 targeted and immune-mediated therapeutics to fight cancer [...]

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

23/08/2024 - 22:30

CAMBRIDGE, Mass., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. ® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with [...]

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

23/08/2024 - 22:30

PROVIDENCE, Rhode Island, Aug. 23, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. ( NASDAQ : OCEA), today announced that on August 19, 2024, it received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) stating that [...]

ARCA biopharma Announces 1-for-12 Reverse Stock Split in Connection with the Proposed Merger with Oruka Therapeutics

23/08/2024 - 22:30

WESTMINSTER, Colo., Aug. 23, 2024 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (NASDAQ: ABIO) (“ARCA”) today announced that its Board of Directors (the “Board”) has approved a reverse stock split of ARCA’s common stock at a [...]

SciSparc Submitted IND Application to the FDA for SCI-110 Phase IIb Clinical Trial for Patients with Tourette Syndrome

23/08/2024 - 22:09

SciSparc to conduct the trial at the Yale Child Study Center at the Yale School of Medicine in the USA, Hannover Medical School in Germany and Tel Aviv Sourasky Medical Center in Israel TEL AVIV, Israel, Aug. 23, 2024 ( [...]

NurExone Biologic Invited to Present Groundbreaking ExoPTEN Therapy at Prestigious September Conferences

23/08/2024 - 22:03

Participation in the events in Boston and New York highlights the Company's prominence in regenerative medicine and exosome technology TORONTO and HAIFA, Israel, Aug. 23, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc [...]

Sienna Senior Living Inc. Announces DBRS Credit Rating Update

23/08/2024 - 21:43

MARKHAM, Ontario, Aug. 23, 2024 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) announced the confirmation by Dominion Bond Rating Service (“DBRS”) of the Company’s BBB Issuer [...]